Eversept Partners, LP Karyopharm Therapeutics Inc. Transaction History
Eversept Partners, LP
- $991 Million
- Q4 2024
A detailed history of Eversept Partners, LP transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Eversept Partners, LP holds 2,088,757 shares of KPTI stock, worth $1.3 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
2,088,757
Previous 5,547,880
62.35%
Holding current value
$1.3 Million
Previous $4.6 Million
69.16%
% of portfolio
0.14%
Previous 0.36%
Shares
4 transactions
Others Institutions Holding KPTI
# of Institutions
98Shares Held
57.1MCall Options Held
604KPut Options Held
71.2K-
Vanguard Group Inc Valley Forge, PA7.65MShares$4.75 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.32MShares$3.92 Million0.01% of portfolio
-
Palo Alto Investors LP Palo Alto, CA4.91MShares$3.04 Million0.53% of portfolio
-
Black Rock Inc. New York, NY4.17MShares$2.59 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.51MShares$2.18 Million0.0% of portfolio
About Karyopharm Therapeutics Inc.
- Ticker KPTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,806,600
- Market Cap $49.5M
- Description
- Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...